taheebo

Action and Spectrum

Actions and Spectrum: 

Actions: 

In the early stages of investigation, there is emerging evidence indicating that pau d’arco could play a role in impeding the growth of cancer cells and slowing down tumor progression. The mechanism involves hindering the formation of crucial blood vessels that tumors rely on for sustenance. While these findings hold promise, it’s important to note that the doses required to achieve these potential anticancer effects appear to come with notable and potentially severe side effects in human subjects. This highlights the delicate balance researchers and healthcare professionals must navigate when considering the use of pau d’arco in cancer-related contexts. 

Spectrum: 

Taheebo, containing NQ801, demonstrates various direct and indirect actions that contribute to its potential as an anticancer agent. Direct actions include selective toxic effects on cancer cells, induction of apoptosis, inhibition of neovascularization, and suppression of metastasis infiltration. Indirect actions involve immunostimulation, enhancing the body’s immune response, and antioxidant properties to counteract the effects of environmental factors. Additionally, Taheebo exhibits supplemental actions such as sedation/analgesia, anti-inflammatory effects, and improvement of overall quality of life by promoting detoxification and metabolic activation. With compounds like paulownin, AX101, and acteoside, Taheebo showcases a range of therapeutic properties, offering potential benefits in cancer management and overall well-being. 

Drug Interaction

Adverse Reaction

Frequency not defined 

Stomachache 

Nausea 

Diarrhea 

Vomiting 

Black Box Warning

Black box warning: 

None 

Contraindication / Caution

Contraindication/Caution: 

Contraindications 

• Hypersensitivity 
• Anticoagulants 
• Pregnancy & breastfeeding 

Cautions 

• Kidney disease 
• Liver disease 
• GI disturbances 

Pregnancy / Lactation

Pregnancy/Lactation: 

Pregnancy consideration: 

No data is available regarding the administration of the drug during pregnancy.  

Breastfeeding warnings: 

No data is available regarding the excretion of drug in breast milk. 

Pregnancy category: 

• Category A: well-controlled and satisfactory studies show no risk to the fetus in the first or later trimester. 
• Category B: There was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. 
• Category C: There was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women. 
• Category D: Adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits. 
• Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women. 
• Category N: No data is available for the drug under this category. 

Pharmacology

Pharmacology: 

Taheebo contains antioxidants combating free radicals, possibly preventing cancer and heart diseases. It may boost the immune system, defending against infections. Beta-lapachone in taheebo might possess anticancer effects by killing cancer cells and restraining tumor growth, though further human studies are required for confirmation. 

Pharmacokinetics 

Limited data available 

Adminstartion

Administration 

Taheebo is consumed in form of tea. 

The route of administration is oral. 

Patient Information Leaflet

Patient information leaflet 

Generic Name: taheebo 

Pronounced: tah-hee-boh 

Why do we use taheebo? 

Taheebo is beneficial for parasite and fungi-related illnesses, treating inflammatory diseases like arthritis, and potentially having anti-cancer properties. It’s traditionally used to promote digestive health and alleviate gastrointestinal issues. Further research is needed.